| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/04/2009 | EP1414410B1 Nanoparticulate formulations of fenofibrate |
| 02/04/2009 | EP0881906B2 Pharmaceutical composition for immunomodulation based on peptides and adjuvants |
| 02/04/2009 | CN101360514A New adjuvants on the basis of bisacyloxypropylcysteine conjugates and their uses in pharmaceutical compositions |
| 02/04/2009 | CN101360513A Biodegradable and thermosensitive poly(organophosphazene) hydrogel, preparation method thereof and use thereof |
| 02/04/2009 | CN101360486A Nanoparticles for protein drug delivery |
| 02/04/2009 | CN101358382A Antibacterial nano fiber material and preparation method thereof |
| 02/04/2009 | CN101358200A RNA interference expression plasmid- cationic liposome-heparin antineoplastic complexes targeting human FAK and PLK1 gene |
| 02/04/2009 | CN101357990A Tadpole polymer with controllable molecular weight and good biocompatibility and preparation method thereof |
| 02/04/2009 | CN101357956A Purification method of polyvinyl alcohol resin |
| 02/04/2009 | CN101357939A Protein conjugate and pharmaceutical compositions thereof |
| 02/04/2009 | CN101357231A Cellular membrane bionics modified nanometer gene vector combination and preparation method thereof |
| 02/04/2009 | CN101357230A Antitumor agents comprising a targeting portion and an immune response triggering portion |
| 02/04/2009 | CN101357223A Preparation method of anti-stress agent for fishing |
| 02/04/2009 | CN101357211A Traditional Chinese medicine navel paste for treating hepatocirrhosis endotoxemia and preparation method thereof |
| 02/04/2009 | CN101357143A Probiotics powder composition and product thereof |
| 02/04/2009 | CN101357130A Oral microparticles containing pseudoephedrine hydrochloride and cetirizine hydrochloride |
| 02/04/2009 | CN101357126A Stable taxone albumin lipid drug-loading system and preparation method thereof |
| 02/04/2009 | CN101357120A Water-soluble drug sustained release microsphere agents and preparation method thereof |
| 02/04/2009 | CN101357119A Medicine microemulsion injection composition and preparation method thereof |
| 02/04/2009 | CN101357108A Skin surface quick film-forming agent |
| 02/04/2009 | CN100457781C Antibodies against cancer |
| 02/04/2009 | CN100457189C Fusions of cytokines and tumor targeting proteins |
| 02/04/2009 | CN100457188C Implantable particles for tissue bulking and the treatment of gastroesophageal reflux diosease |
| 02/04/2009 | CN100457187C VEGF slowly releasing injection microsphere support and its preparation and use |
| 02/04/2009 | CN100457186C Application of saturated fatty polyol or alcoholic acid as cross-linking agent in filming gel composition |
| 02/04/2009 | CN100457185C Coordination complex of diaminocyclohexaneplatinum(II) with block copolymer containing poly(carboxylic acid) segment and antitumor agent comprising the same |
| 02/04/2009 | CN100457184C Multi-stage oral drug controlled-release system |
| 02/04/2009 | CN100457179C Method and composition for oral vaccination |
| 02/04/2009 | CN100457178C Process for preparing bone peptide injection |
| 02/04/2009 | CN100457137C Polylactic acid microglobule Chinese medicine compound used for treating bone arthritis |
| 02/04/2009 | CN100457107C Pharmaceutical preparation containing the active substance taken as heroin and its utilization in a method for treating opiate addiction |
| 02/04/2009 | CN100457103C Double layer osmotic pump controlled release felodipine medicine composition |
| 02/04/2009 | CN100457102C Pharmaceutical compositions |
| 02/04/2009 | CN100457098C Freeze-dried powder injection of nafamostat mesylate and its preparing method |
| 02/04/2009 | CN100457095C Improved transdermal therapeutic system for treatment of Parkinson's disease |
| 02/04/2009 | CN100457094C Preparing process of biodegradable capsule loading medicine and nano magnetic particle |
| 02/04/2009 | CN100457090C Milled particles |
| 02/04/2009 | CN100457088C Pharmaceutical composition comprising lipids comprising polar and nonpolar moiety parts |
| 02/04/2009 | CN100457085C Polyglycol nano preparation coated with Maka, or Kava, or gingerroot, or ginseng oil |
| 02/04/2009 | CN100457084C Nanometer silver type external use antibiotic gel for female external use and its preparation method |
| 02/04/2009 | CN100457078C Cosmetics |
| 02/03/2009 | US7485743 Oligomeric ketone compounds |
| 02/03/2009 | US7485706 Has a domain that preferentially binds to aggregations comprising at least two monomeric proteins linked to a second domain that recruits the aggregation modifying protein; neurotoxicity; neurodegenerative diseases |
| 02/03/2009 | US7485666 Vaginal health products |
| 02/03/2009 | US7485659 Anticancer compositions, and methods of making and using the same |
| 02/03/2009 | US7485656 Fluconazole, a compound selected from a group consisting of fatty acid, fatty alcohol, higher fatty acid ester and lower alcohol and a base; favorable absorption and delivery through the human skin; low skin stimulation; stability; spreading |
| 02/03/2009 | US7485627 Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation |
| 02/03/2009 | US7485422 Using aberrant expression of caudal type homeobox transcription factor 2 (CDX2) as diagnostic indicator of stomach or esophageal cell proliferative disorers |
| 02/03/2009 | US7485421 peptide nucleic acids used as gene expression inhibitors and as probes for detection of nucleic acids |
| 02/03/2009 | US7485321 Synthetic polypeptide ligand having a 12-mer L-peptide for targeting pharmaceutical agents to intestinal epithelial tissue; when integrated as an N-terminal PIII fusion peptide of an M13 phage it can bind the phage to Caco-2 cell, IEC-6 cell, rat, mouse, pig or dog homogenate membrane fractions |
| 02/03/2009 | US7485318 Biodegradable carrier and method for preparation thereof |
| 02/03/2009 | US7485317 Thermo-reversible polymer for intralumenal implant |
| 02/03/2009 | US7485302 Treatment with anti-ErbB2 antibodies and chemotherapeutic agents |
| 02/03/2009 | US7485296 Using monoclonal antibodies specific for prostate stem cell antigen (PSCA) for use in diagnosis and treatment of cell proliferfative disorders; immunodiagnostics; immunotherapy |
| 02/03/2009 | US7485285 Delivery of antidepressants through an inhalation route |
| 02/03/2009 | US7485183 Pigment mixture containing at least two components, component A is an effect pigment(s) based on thin glass flakes and component B comprises flake-form, needle-shaped, spherical or crystalline colorants or fillers |
| 02/03/2009 | CA2455208C Method of encapsulating an active substance |
| 02/03/2009 | CA2382902C Rapidly decomposing chitosan-based pellets |
| 02/03/2009 | CA2361377C Novel mucosal delivery system |
| 02/03/2009 | CA2341397C Immediate release tablet |
| 02/03/2009 | CA2316224C Microcapsules; process for preparing microcapsules containing a biologically active compound and liquid solution |
| 02/03/2009 | CA2314716C Modified polysaccharides exhibiting altered biological recognition |
| 02/03/2009 | CA2275321C Medical composition and use thereof for the manufacture of a topical barrier formulation, a uv-radiation absorbing formulation, or an antiviral, antifungal, or antiinflammatory formulation |
| 02/03/2009 | CA2150925C Improved synthesis of polymer bio-active conjugates |
| 02/01/2009 | CA2595485A1 Liposomal compositions for parenteral delivery of statins |
| 01/29/2009 | WO2009015345A1 Pharmaceutical compositions comprising fc fusion proteins |
| 01/29/2009 | WO2009014510A1 Pharmaceutical formulation for delivery of receptor tyrosine kinase inhibiting (rtki) compounds to the eye |
| 01/29/2009 | WO2009013972A1 Immunoadjuvant and method of assaying iga antibody |
| 01/29/2009 | WO2009013864A1 Vesicle composition and external preparation for skin |
| 01/29/2009 | WO2009013770A1 Derivatised polysaccharide material for the transdermal administration of drugs |
| 01/29/2009 | WO2009013484A1 Immune modulation via c-type lectin |
| 01/29/2009 | WO2009013448A2 Herpesviruses having altered target cell specificity |
| 01/29/2009 | WO2009013435A2 Preservative-free prostaglandin-based ophthalmic solution |
| 01/29/2009 | WO2009013359A2 Self coupling recombinant antibody fusion proteins |
| 01/29/2009 | WO2009013261A2 Derivatised polysaccharide material for the topic antibacterial activity |
| 01/29/2009 | WO2009012944A1 A conjugate of an antibody against cd4 and antifusogenic peptides |
| 01/29/2009 | WO2009012908A2 Medicament for transdermal use on animals |
| 01/29/2009 | WO2009012901A2 Material compositions which comprise adult stem cells obtained from exocrine glandular tissue, in particular for use in regenerative medicine, e.g. for restoring injured or damaged myocardial tissue |
| 01/29/2009 | WO2009012601A1 Antigen-adjuvant compositions and methods |
| 01/29/2009 | WO2009012600A1 Fusion proteins |
| 01/29/2009 | WO2009012551A1 Resveratrol complex and process for the preperation |
| 01/29/2009 | WO2008148212A3 High-amylose sodium carboxymethyl starch sustained release excipient and process for preparing the same |
| 01/29/2009 | WO2008136773A8 Functionalization of nanoparticles by glucosamine derivatives |
| 01/29/2009 | WO2008120207A3 Compositions for nasal delivery |
| 01/29/2009 | WO2008087034A3 Cyclodextrin formulations |
| 01/29/2009 | WO2008076333A9 Polymer-drug conjugates with tether groups for controlled drug delivery |
| 01/29/2009 | WO2008075207A3 Anti-infection augmentation foamable compositions and kit and uses thereof |
| 01/29/2009 | WO2008075204A3 Lipoic acid derivatives |
| 01/29/2009 | WO2008004992A3 Transdermal formulations containing hepatitis c virus immunogens and an ethoxylated oil |
| 01/29/2009 | WO2007095749A8 Cytotoxicity mediation of cells evidencing surface expression of trop-2 |
| 01/29/2009 | US20090030183 Interferon Beta-Like Molecules |
| 01/29/2009 | US20090030093 Method for emulsion polymerisation of olefins |
| 01/29/2009 | US20090030092 Thickening agent |
| 01/29/2009 | US20090030091 Brown Film Composition and Method for Preparing the Same |
| 01/29/2009 | US20090030090 Carbon nanotube reinforced polymer nanocomposites |
| 01/29/2009 | US20090030089 Silicon Substituted Oxyapatite |
| 01/29/2009 | US20090030064 Sugar-coated preparation |
| 01/29/2009 | US20090029937 Biodegradable cationic polymer gene transfer compositions and methods of use |
| 01/29/2009 | US20090029911 Liquid Human Growth Hormone Formulation Containing Polyethylene Glycol |
| 01/29/2009 | US20090029467 contacting targeted therapeutic with a cell deficient in a lysosomal enzyme, wherein the cell expresses the cation-independent mannose-6-phosphate receptor on the surface, thereby targeting the therapeutic enzyme to the lysosome; insulin-like growth factor 2 receptor |